Abstract
Although radiation therapy has an established role to play in the management of rectal and anal tumors, there are often treatment-related morbidities that negatively impact on patients. There is a long-standing interest in radiation oncology on maximizing treatment efficacy while minimizing treatment-related toxicities, which can be pronounced in the treatment of pelvic malignancies. Intensity-modulated radiation therapy is a recently introduced technology that has the potential to increase the efficacy:toxicity ratio. It has been implemented in the treatment of prostate and head and neck tumors with success. This article reviews the rationale for its use in treating anorectal tumors and discusses early clinical data supporting its continued investigation.
Original language | English (US) |
---|---|
Pages (from-to) | 585-593 |
Number of pages | 9 |
Journal | Expert Review of Anticancer Therapy |
Volume | 8 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2008 |
Externally published | Yes |
Keywords
- IMRT
- Intensity-modulated radiation therapy
- Radiation
- Rectum
- Tolerance
- Toxicity
ASJC Scopus subject areas
- Oncology
- Pharmacology (medical)